Brett Alan Palmer

Northwestern University — United States

Medicine · Health Sciences

9h-index358citations20works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lymphoma Diagnosis and Treatment(12), Lung Cancer Treatments and Mutations(5), Cancer Immunotherapy and Biomarkers(4), Chronic Lymphocytic Leukemia Research(4), Cancer Genomics and Diagnostics(4)

Publications20 total

Multicenter phase 2 study of romidepsin plus lenalidomide for previously untreated peripheral T-cell lymphoma
Blood Advances·2023· 32 citedOpen Access
Pembrolizumab Added to Ifosfamide, Carboplatin, and Etoposide Chemotherapy for Relapsed or Refractory Classic Hodgkin Lymphoma
JAMA Oncology·2023· 56 citedOpen Access
Sequential pembrolizumab and AVD are highly effective at any PD-L1 expression level in untreated Hodgkin lymphoma
Blood Advances·2022· 31 citedOpen Access
Frontline Treatment with Single Agent Pembrolizumab (PEM) Followed By AVD Chemotherapy for Classic Hodgkin Lymphoma: Updated Results and Correlative Analysis
Blood·2021· 2 cited
Phase I Study of Novel SYK Inhibitor TAK-659 in Combination with R-CHOP for Front-Line Treatment of High Risk Diffuse Large B-Cell Lymphoma
Blood·2021
Pembrolizumab (PEM) Added to ICE Chemotherapy Results in High Complete Metabolic Response Rates in Relapsed/Refractory Classic Hodgkin Lymphoma (cHL): A Multi-Institutional Phase II Trial
Blood·2021· 18 cited
MULTI‐CENTER PHASE II STUDY OF ROMIDEPSIN PLUS LENALIDOMIDE FOR PATIENTS WITH PREVIOUSLY UNTREATED PERIPHERAL T‐CELL LYMPHOMA (PTCL)
Hematological Oncology·2021· 3 citedOpen Access
Multicenter phase II study of romidepsin plus lenalidomide for patients with previously untreated peripheral T-cell lymphoma (PTCL).
Journal of Clinical Oncology·2021· 6 cited
CAUSE OF CHEST PAIN - SARS-COV-2
Journal of the American College of Cardiology·2021Open Access
A Phase I-II Trial of DA-EPOCH-R Plus Ixazomib As Frontline Therapy for Patients with MYC-Aberrant Lymphoid Malignancies: The Daciphor Regimen
Blood·2020· 3 cited
PD-L1 Pathway Markers and Chromosome 9p24.1 Alterations in Patients with Classic Hodgkin Lymphoma Treated with Frontline Single Agent Pembrolizumab (PEM) Followed By AVD Chemotherapy
Blood·2020
Pembrolizumab followed by AVD in untreated early unfavorable and advanced-stage classical Hodgkin lymphoma
Blood·2020· 136 citedOpen Access
ABCL-283: A Phase I/II Trial of Brentuximab Vedotin (BV) Plus Rituximab (R) as Frontline Therapy for Patients with Immunosuppression-Associated CD30+ and/or EBV+ Lymphomas
Clinical Lymphoma Myeloma & Leukemia·2020· 4 cited
Brief Pembrolizumab(PEM) Monotherapy Results in Complete and Near Complete Responses in the Majority of Untreated Patients with Classical Hodgkin Lymphoma (cHL): A Multicenter Phase 2 PET-Adapted Study of Sequential PEM and AVD
Blood·2019· 11 cited
Safety and Toxicity Profile of Pembrolizumab (PEM) in Combination with ICE Chemotherapy Followed By Autologous Stem Cell Transplantation for Relapsed/Refractory Classical Hodgkin Lymphoma: No Impairment in Stem Cell Mobilization or Engraftment
Blood·2019· 9 cited
2019 Student Steel Bridge Team
Rowan Digitals Works (Rowan University)·2019Open Access
A Phase II Study of Sequential Pembrolizumab (PEM) Followed By AVD for Frontline Treatment of Classical Hodgkin Lymphoma (CHL): Quantifying Response Following PEM Monotherapy with FDG-PET-Derived Metabolic Tumor Volume and Total Lesion Glycolysis
Blood·2018· 9 cited
Effects of fasting and glucocorticoids on hepatic gluconeogenesis assessed using two independent methods in vivo
American Journal of Physiology-Endocrinology and Metabolism·2002· 31 cited
Effects of cyclosporine A and prednisone treatment on mixed meal disposition in dogs with hepatic denervation
Journal of Parenteral and Enteral Nutrition·2002· 4 cited
Disposition of a Mixed Meal by Conscious Dogs after Seven Days of Treatment with Cyclosporine A and Prednisone
Journal of Parenteral and Enteral Nutrition·2000· 3 cited

Frequent Co-authors

Barbara Pro(15), Jane N. Winter(15), Leo I. Gordon(14), Reem Karmali(13), Pamela B. Allen(9), Hatice Savas(9), Andrew M. Evens(8), Gary Dillehay(6), Joan S. Chmiel(6), Ranjana H. Advani(5), Eric Mou(5), Kaitlyn O’Shea(5), Borko Jovanovic(4), Xinlei Mi(4), Jeffrey Bearden(3), Locke J. Bryan(3), Carla Casulo(3), Scott E. Smith(3), Jayesh Mehta(3), Jia Ruan(3)